Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, Anhui, China.
Department of Breast Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, Anhui, China.
J Cancer Res Ther. 2023 Dec 1;19(6):1568-1574. doi: 10.4103/jcrt.jcrt_51_23. Epub 2023 Dec 28.
The aim of this study was to compare the advantages and disadvantages of intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with left-sided breast cancer who underwent hypofractionated IMRT after a modified radical mastectomy.
Twenty patients who required adjuvant radiotherapy after modified radical mastectomy were randomly selected, and a specified dose of 43.5 Gy/15 F was used to plan for IMRT or VMAT. Dose-volume histograms (DVHs) were utilized to evaluate the dose distribution of the planning target volumes (PTVs) and organs at risk (OARs).
VMAT demonstrated a greater and more uniform dose distribution of PTVs and lower number of monitor units. No significant differences were found in V5 of the affected lung and heart between the two techniques (P > 0.05). The V10, V20, V30, and Dmean of the affected lung and V10, V20, V30, V40, Dmean, and Dmax of the whole heart were better in the VMAT than in the IMRT (P < 0.05). The Dmean and Dmax of the left anterior descending (LAD) branch of the coronary artery of the heart were better in the VMAT (P < 0.05), and the use of the VMAT effectively reduced the cardiopulmonary dose. A significant advantage of V30 and Dmean was also found in VMAT (P < 0.05).
These findings indicate that VMAT has higher clinical significance than IMRT, because it improved the dose distribution in the target area, reduced the cardiopulmonary dose, protected the OARs (e.g. thyroid), and shortened the treatment duration.
本研究旨在比较左侧乳腺癌患者接受改良根治性乳房切除术后接受调强放疗(IMRT)和容积调强弧形治疗(VMAT)的优缺点。
随机选择 20 例接受改良根治性乳房切除术后需要辅助放疗的患者,指定剂量为 43.5Gy/15F 用于规划 IMRT 或 VMAT。利用剂量体积直方图(DVH)评估计划靶区(PTV)和危及器官(OAR)的剂量分布。
VMAT 显示出更大、更均匀的 PTV 剂量分布和更低的监测器单位数。两种技术之间,受影响的肺和心脏的 V5 无显著差异(P>0.05)。受影响的肺的 V10、V20、V30 和 Dmean 以及整个心脏的 V10、V20、V30、V40、Dmean 和 Dmax 在 VMAT 中优于 IMRT(P<0.05)。心脏的左前降支(LAD)分支的 Dmean 和 Dmax 在 VMAT 中更好(P<0.05),并且 VMAT 的使用有效地降低了心肺剂量。在 VMAT 中还发现 V30 和 Dmean 的显著优势(P<0.05)。
这些发现表明,VMAT 比 IMRT 具有更高的临床意义,因为它改善了靶区的剂量分布,降低了心肺剂量,保护了 OARs(如甲状腺),并缩短了治疗时间。